Physician

Jatin K Kadakia, MD

According to 2025 Medicare claims, Jatin Kadakia, MD (NPI: 1831262385) practices internal medicine in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Montgomery, TN. This provider's primary affiliated billing organization is CLARKSVILLE PULMONARY & CRITICAL CARE, PC (NPI: 1548333099; TIN: 62-1556922) and primary practice location at 37043-6319.

Kadakia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 870 traditional Medicare patients, billed 7,178 HCPCS/CPT codes, and received $324,202 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,215 prescription claims across 385 beneficiaries totaling $1,038,607 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 5,197 claims. Open Payments data shows 123 records totaling $2,549. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $474,397 to $324,202. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $335,900 to $1,038,607. For DME billing, reported payments moved up and down with repeated peaks and valleys, starting at $473,422 and ending at $220,241.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,115	8,330	$474,397
2016	1,080	10,356	$525,143
2017	1,110	8,144	$454,006
2018	1,012	11,392	$563,944
2019	947	7,439	$399,641
2020	882	5,743	$309,383
2021	912	5,471	$345,623
2022	824	4,786	$282,848
2023	848	5,595	$335,634
2024	870	7,178	$324,202

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	312	2,500	$335,900
2016	332	2,344	$400,746
2017	342	2,754	$598,204
2018	331	2,265	$678,485
2019	330	2,161	$700,231
2020	347	2,311	$662,842
2021	334	2,207	$842,480
2022	333	1,864	$794,691
2023	375	2,154	$896,941
2024	385	2,215	$1,038,607

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	2,315	7,697	$581,534
2016	2,219	7,054	$345,750
2017	2,314	7,357	$298,395
2018	2,071	6,524	$280,894
2019	2,113	6,219	$297,524
2020	2,211	6,254	$340,394
2021	1,976	5,633	$311,467
2022	1,650	4,520	$252,777
2023	1,805	4,583	$275,278
2024	1,789	5,197	$245,887

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	633	1,488	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	474	742	$61
94729	Test to examine how well the lungs exchange gases	271	276	$39
94726	Test to determine lung volumes using sensors	296	301	$36
94060	Test to measure expiratory airflow and volume changes before and after medication administration	479	750	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	341	14,370	$299,514
Opsumit	Macitentan	13	390	$164,493
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	104	3,899	$82,646
Ambrisentan	Ambrisentan	14	420	$39,900
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	49	2,130	$32,403

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	72	509	$37,930
A7031	Face mask interface, replacement for full face mask, each	N	148	399	$30,393
A7030	Full face mask used with positive airway pressure device, each	N	154	379	$29,831
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	22	$22,139
J7677	Revefenacin inhalation solution, fda-approved final product, non-compounded, administered through dme, 1 microgram	N	N/R	25	$21,921

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	123	$2,549	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jatin K. Kadakia, MD?

Tedicare shows public-source Medicare data for Jatin K. Kadakia, MD (NPI 1831262385), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jatin K. Kadakia, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jatin K. Kadakia, MD?

Jatin K. Kadakia, MD is linked to CLARKSVILLE PULMONARY & CRITICAL CARE, PC (billing NPI 1548333099) in the available physician profile data.

Does Jatin K. Kadakia, MD have Open Payments data?

Jatin K. Kadakia, MD has 123 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.